Asia Pacific Semi-solid Dosage Cdmo Market Size & Outlook

The semi-solid dosage cdmo market in Asia Pacific is expected to reach a projected revenue of US$ 16,335.7 million by 2030. A compound annual growth rate of 13.3% is expected of Asia Pacific semi-solid dosage cdmo market from 2024 to 2030.
Revenue, 2023 (US$M)
$6,833.5
Forecast, 2030 (US$M)
$16,335.7
CAGR, 2024 - 2030
13.3%
Report Coverage
Asia Pacific

Asia Pacific semi-solid dosage cdmo market, 2018-2030 (US$M)

Asia
Unlock Premium

Asia Pacific semi-solid dosage cdmo market highlights

  • The Asia Pacific semi-solid dosage cdmo market generated a revenue of USD 6,833.5 million in 2023.
  • The market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
  • In terms of segment, topical was the largest revenue generating route of administration in 2023.
  • Topical is the most lucrative route of administration segment registering the fastest growth during the forecast period.


Asia Pacific data book summary

Market revenue in 2023USD 6,833.5 million
Market revenue in 2030USD 16,335.7 million
Growth rate13.3% (CAGR from 2023 to 2030)
Largest segmentTopical
Fastest growing segmentTopical
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTopical


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.0% of the global semi-solid dosage cdmo market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 16,335.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Semi-Solid Dosage CDMO Market Scope

Semi-solid dosage cdmo market segmentation & scope
Transdermal
Others
Product
Ointments
Creams and Lotions
Gels
Others
Service
Contract Manufacturing
Contract Development
End Use
Pharmaceutical Companies
Biopharmaceutical Companies
Others
Countries
Canada
Mexico
U.S.
Denmark
France
Germany
Italy
Norway
Spain
Sweden
UK
Australia
China
India
Japan
South Korea
Thailand
Argentina
Brazil
Kuwait
Saudi Arabia
South Africa
UAE

Semi-Solid Dosage CDMO Market Companies

Name Profile # Employees HQ Website

Asia Pacific semi-solid dosage cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to semi-solid dosage cdmo market will help companies and investors design strategic landscapes.


Topical was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific semi-solid dosage cdmo market based on topical covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific semi-solid dosage cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific semi-solid dosage cdmo market databook

  • Our clientele includes a mix of semi-solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific semi-solid dosage cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific semi-solid dosage cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific semi-solid dosage cdmo market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more